Ara mostrant els elements 1-8 de 8
Bassani, Nicklas (Data de defensa: 2017-12-15)
Antiangiogenic drugs are used clinically for treatment of different types of cancers and in the case of renal cell carcinoma (RCC) are now standard first-line treatments (Rini, 2009). Nevertheless, these ...
Herrera Camacho, Antonio (Data de defensa: 2015-11-06)
El meduloblastoma es un tumor cerebral maligno localizado en la fosa posterior del cráneo, con una muy alta incidencia en niños. Hasta cuatro distintos subgrupos de meduloblastomas pueden ser definidos ...
Sala Hojman, Ada (Data de defensa: 2016-07-15)
LIF is a pleiotropic cytokine that can act as an immunomodulatory factor in different biological processes, such as embryo implantation, organ transplantation tolerance and multiple sclerosis. Here, we ...
Bazzocco, Sarah (Data de defensa: 2016-01-27)
Colorectal cancer is a disease caused by genetic and epigenetic changes. Inactivation of tumor suppressor genes and activation of oncogenes are key landmarks in tumor progression. However, the list of ...
De Mol, Eva (Data de defensa: 2014-06-26)
Prostate cancer (PCa) is the second most common cancer in men after lung cancer. Around 1.1 million men worldwide were diagnosed with PCa in 2012. PCa depends essentially on androgen stimulation for ...
Puig Saus, Cristina (Data de defensa: 2013-07-15)
La viroteràpia amb adenovirus oncolítics es basa en la lisi selectiva de la cèl•lula tumoral a través de la replicació viral. Les principals limitacions d’aquesta teràpia són: la limitada arribada del ...
Martínez Redondo, Paloma (Data de defensa: 2014-06-25)
The chromatin consists of a hierarchical and dynamical structure that is modulated during the different cell cycle stages in order to maintain genome integrity and preserve the genetic information coded ...
Terribas Pérez, Ernest (Data de defensa: 2016-01-20)
Malignant peripheral nerve sheath tumour (MPNST) is a soft tissue sarcoma of the peripheral nervous system. Around 50% of MPNSTs develop in the context of the hereditary cancer neurofibromatosis type 1 ...